InMed Pharmaceuticals (INM) EPS (Weighted Average and Diluted) Growth (3y) (2025)

InMed Pharmaceuticals (INM) EPS (Weighted Average and Diluted) Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 52.55%
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 6.07%
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 6.19%
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -46.43%
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 64.08%
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -19.39%
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -16.96%
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 260.88%
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -100.00%
10 InMed Pharmaceuticals 5.94 Mn 696,491.41 - -

Historic Data

Download Data
DateValue
Mar 31, 2025 33.24%